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Abstract
Aims:Mechanogated ion channels are predicted to mediate pressure-induced myogenic vasoconstriction in small resistance
arteries. Recent findings have indicated that transient receptor potential (TRP) channels and epithelial sodium channels
(ENaC) are involved in mechanotransduction. The purpose of this study was to investigate the role of TRP channels and
ENaC in the myogenic response. Our previous study suggested that ENaC could be a component of the mechanosensitive
ion channels in rat posterior cerebral arteries (PCA). However, the specific ion channel proteins mediating myogenic
constriction are unknown. Here we found, for the first time, that ENaC interacted with TRPM4 but not with TRPC6 using
immunoprecipitation and confocal microscopy.
Methods and Results: Treatment with a specific bENaC inhibitor, amiloride, a specific TRPM4 inhibitor, 9-phenanthrol, and a
TRPC6 inhibitor, SKF96365, resulted in inhibition of the pressure-induced myogenic response. Moreover, the myogenic
response was inhibited in rat PCA transfected with small interfering RNA of bENaC, TRPM4, and TRPC6. Co-treatment with
amiloride and 9-phenanthrol showed a similar inhibitory effect on myogenic contraction compared to single treatment with
amiloride or 9-phenanthrol. The myogenic response was not affected by 9-phenanthrol or amiloride treatment in PCA
transfected with bENaC or TRPM4 siRNA, respectively. However, pressure-induced myogenic response was fully inhibited by
co-treatment with amiloride, 9-phenanthrol, and SKF96365, and by treatment with SKF96365 in PCA transfected with bENaC
siRNA.
Conclusion: Our results suggest that ENaC, TRPM4, and TRPC6 play important roles in the pressure-induced myogenic
response, and that ENaC and TRPM4 interact in rat PCA.
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Introduction
In many vessels, such as coronary, mesenteric, renal, and
cerebral arteries, blood flow is tightly regulated despite changes in
systemic perfusion pressure [1–4]. Within the physiological
perfusion pressure range, small resistant arteries respond to an
acute increase in pressure by vasoconstricting and to a decrease in
pressure by vasodilating. This behavior, termed the myogenic
response, is inherent to vascular smooth muscle in the vessel wall
of small arteries and arterioles and is not dependent on the
endothelium or the nervous system [2,5,6]. The myogenic
response has been described in many vessels including cerebral,
mesenteric, renal, femoral, and pulmonary arteries [7–11].
Alterations in the myogenic response have been shown to be
associated with diseases such as hypertension and diabetes [12].
The functional importance of the myogenic response in health and
disease had made it one of the most intensively investigated topics
in circulatory physiology. Although the pressure-dependent
myogenic response has been intensively investigated, the molec-
ular mechanisms underlying the transduction of pressure into a
cellular event in vascular smooth muscle cells (VSMCs) are still
unclear.
Recent findings have indicated that two kinds of ion channels,
transient receptor potential (TRP) channels and amiloride-
sensitive epithelial sodium channels (ENaC) are involved in
cellular mechanotransduction [13–20]. The most well-known role
of ENaC is related to Na+ reabsorption in many epithelia, such as
the kidney, distal colon, secretory glands, and respiratory airways.
Because of their close evolutionary relationship to the C. elegans
degenerins [21] and their requirement for normal mechanosen-
sory responses, ENaC proteins are considered to be components of
mechanosensitive ion channel complexes in vertebrate tissue.
Recently identified mammalian TRP channels are also candi-
dates for mechanosensory functions in arterial smooth muscle
[22]. Most TRP channels are non-selective cation channels
permeable to calcium which have been implicated in a large
variety of sensory functions [23]. Two members of the TRP
family, TRPC6 and TRPM4, are considered to be mediators of
pressure-induced myogenic constriction in cerebral vessels [13,16].
ENaC [14,19], TRPC6 [13,24], and TRPM4 [15,16] are
expressed in rat cerebellar and posterior cerebral arteries (PCA).
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We also previously showed that the ENaC is critically involved in
the cerebrovascular myogenic response. Thus, the goal of this
study was to determine the roles of ENaC, TRPM4, and TRPC6
in the contractile response to pressure, and to investigate the
functional relationships among ENaC, TRPM4, and TRPC6. We
therefore examined the expression of ENaC, TRPC6, and
TRPM4 in rat PCA. In addition, we analyzed the contributions
of ENaC, TRPC6, and TRPM4 to the contractile response to
pressure in the presence of pharmacological inhibitors such as
amiloride, 9-phenanthrol and SKF96365, and in siRNA trans-
fected rat PCA. The relationship between TRP channels and
ENaC was also evaluated.
Methods
This investigation was conducted in compliance with the Guide
for the Care and Use of Laboratory Animals published by US National
Institutes of Health (NIH publication No. 85–23, revised 1996).
The experimental protocols used in this study were approved by
the Ethics Committee and the Institutional Animal Care and Use
Committee of Yonsei University, College of Medicine.
Tissue preparation
Seventy adult male Sprague-Dawley rats were used in this
study. Rats were anesthetized with sodium pentobarbital (50 mg/
kg, i.p.). The depth of anesthesia was evaluated by pinching the
animal’s paw with forceps. Rat brains were isolated and placed in
chilled normal Krebs-Henseleit (KH) solution composed of (in
mmol/L): NaCl, 119; CaCl2, 2.5; NaHCO3, 25; MgSO4, 1.2;
KH2PO4, 1.2; KCl, 4.6; and glucose, 11.1. PCAs were dissected
from the brain, cleaned of connective tissue, and segmented into
about 3–4 mm lengths. To eliminate the potential influence of
endothelial factors on pressure-induced myogenic tone, an air
bolus was passed through the lumen to disrupt the endothelium.
PCA segments lacking a vasodilatory response to acetylcholine
(1 mmol/L), but exhibiting efficient constriction to serotonin
(10 mmol/L), were included in the studies.
Measurement of myogenic tone using an arteriograph
system
Rat PCA segments (100–250 mm inner diameter) were cannu-
lated and mounted in a pressure myograph (Living Systems
Instrumentation, Burlington, VT, USA) as previously described
[19]. Briefly, the de-endothelialized cerebral arterial segments
were stretched longitudinally to approximate in situ length and
maintained at an intraluminal pressure of 40 mmHg for a 40 min
equilibration period. After the equilibration period, the pressure
was increased in a stepwise manner from 20 to 120 mmHg in 20-
mmHg increments, and each pressure was maintained for 10 min
to allow the vessel diameter to stabilize before measurements.
Figure 1. Localization of ENaC, TRPM4, and TRPC6 in rat PCA. A–C: Immunofluorescence of TRPC6 and cENaC (A), TRPM4 and cENaC (B), and
TRPM4 and TRPC6 (C). The arrow and yellow coloration denotes co-localization of channels in merged images. Blue colors indicate the nucleus.
doi:10.1371/journal.pone.0084194.g001
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Small interfering RNA transfection of cerebral arteries
Rat PCA was transfected with small interfering RNA (siRNA) as
previously described [19]. Briefly, the segments were separated
into four groups for transfection with non-targeting (NT) siRNA,
bENaC siRNA, TRPM4 siRNA,or TRPC6 siRNA (Bioneer Inc.,
Daejeon, Korea). A final amount of 10 mg siRNA for bENaC,
20 mg (first pair 10 mg + second pair 10 mg) for TRPM4, or 20 mg
(first pair 10 mg + second pair 10 mg) for TRPC6 was transfected
with LipofectamineTM 2000 (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s instructions. siRNA duplexes
were designed with RNAi designer software (Ambion, Austin, TX,
USA) using accession number NM012648 for bENaC,
NM001136229 for TRPM4, and NM053559 for TRPC6. The
NT siRNA was purchased from Bioneer Inc. The sequences of
bEnaC siRNA duplexes were: forward, 59-GGAGCUGCUAGU-
GUGGUACdTdT-39; reverse: 59-GUACCACACUAGCAGCU-
CCdTdT-39. The first pair of sequences of TRPM4 siRNA were:
forward, 59-AGAGAGGAUCAUGACCCGAA-39; reverse: 59-U-
UCGGGUCAUGAUCCUCUCU-39. The second pair of sequen-
ces of TRPM4 siRNA were: forward, 59-CCUGGGUAACGUG-
GUCAGUUA-39; reverse, 59-UAACUGACCACGUUACCCA-
GG-39. The first pair of sequences of TRPC6 siRNA were:
forward, 59-GAACGGCCUCAUGAUUAUUdTdT-39; reverse,
59-AAUAAUCAUGAGGCCGUUCdTdT-39. The second pair of
sequences of TRPP6 siRNA were: forward, 59-GUGUACA-
GAAUGCAGCCAGdTdT-39; reverse: 59-CUGGCUGCAUU-
CUGUACACdTdT-39. The sequences of the NT siRNA duplexes
were: forward, 59-CCUACGCCACCAAUUUCGUdTdT-39; re-
verse, 59-ACGAAAUUGGUGGCGUAGGdTdT-39. Knock-
down efficiency was assessed by western blotting.
Immunofluorescence of cENaC, TRPM4, and TRPC6
proteins in PCAs
The expression and localization of cENaC, TRPM4, and
TRPC6 proteins in isolated rat PCAs were measured using
immunostaining as previously described [25]. The PCAs were
probed with cENaC antibody (1:200 dilution; Millipore, Teme-
cula, CA, USA), TRPC6 antibody (1:200 dilution; Abcam,
Cambridge, UK), or TRPM4 antibody (1:200 dilution; Abcam).
DAPI was used for nuclear staining (Vector Laboratories,
Burlingame, CA, USA).
Western blotting
The expression of bENaC, TRPC6, and TRPM4 proteins in rat
PCA was measured by western blot as previously described [26].
Membranes were probed with bENaC antibody (1:200 dilution;
Millipore), TRPM4 antibody (1:200 dilution; Abcam), TRPC6
antibody (1:200 dilution; Abcam), or actin antibody (1:1000
dilution; Abcam) as the loading control. Bands were detected and
quantified using Fuji Photo Film Image with the Fuji film image
gauge program (version 2.54; Fuji Photo Film Co., Tokyo, Japan).
Immunoprecipitation
Tissue homogenates were incubated with cENaC antibody
overnight at 4uC. After incubation with protein G agarose beads
for 2 h, precipitates were washed with lysis buffer and then
resuspended in SDS-PAGE sample buffer. Samples were dena-
tured at 100uC for 5 min prior to separation by SDS-PAGE.
Figure 2. Effects of ENaC, TRPM4, and TRPC6 inhibition on the pressure-induced myogenic response. A–C. Representative recording
showing the effect of 1 mmol/L amiloride (A), 5 mmol/L 9-phenanthrol (B), and 1 mmol/L SKF96365 (C), respectively. D. Mean data for the effect of
amiloride, 9-phenanthrol, and SKF96365. Data are expressed as means 6 SEM (n= 6) and are normalized to myogenic tone at a diameter of
40 mmHg. *p,0.05 for control vs. treatment with amiloride, 9-phenanthrol or SKF96365.
doi:10.1371/journal.pone.0084194.g002
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Drugs
The following drugs were used: amiloride (Tocris Bioscience,
Ellisville, MO, USA); SKF96365 hydrochloride (Tocris Biosci-
ence); 9-phenanthrol (Sigma-Aldrich, St Louis, MO, USA); and
nifedipine (Sigma-Aldrich). The general laboratory reagents used
were analytical grade or better.
Statistics
All values given in the text are expressed as means 6 SEM and
were analyzed by two-way ANOVA, followed by Student–
Newman–Keuls posthoc test. Differences were considered signif-
icant at the P,0.05 level.
Results
Localization of ENaC, TRPC6, and TRPM4 in rat PCA
ENaC, TRPC6, and TRPM4 were expressed in rat PCA and
typical immunofluorescent staining in PCA segments showed that
ENaC, TRPC6, and TRPM4 were localized near the cell surface
(Fig. 1A, B, & C).
Effects of amiloride, SKF96365, and 9-phenanthrol on
myogenic tone of PCA
To determine whether ENaC, TRPC6, and TRPM4 proteins
are required for the myogenic response, we evaluated myogenic
tone in isolated PCA in the presence and absence of inhibitors.
Figure 2A, B, and C indicate the typical traces showing effects of
ENaC, TRPM4, and TRPC6 blockade on PCA, respectively.
When intraluminal pressure was increased in a stepwise manner
from 20 to 120 mmHg, the PCA contracted in response to an
increase in intraluminal pressure, whereas, in Ca2+-free KH bath
solution, vessels dilated passively in response to increases in
intraluminal pressure. As shown in Figure 2, the myogenic tone in
response to an increase in intraluminal pressure was inhibited by
treatment with ENaC inhibitor amiloride (1 mM, Fig 2A) TRPM4
inhibitor 9-phenanthrol (5 mM, Fig 2B) and TRPC6 inhibitor
SKF96365 (1 mM, Fig 2C). The myogenic tone was significantly
inhibited by treatment of the inhibitors (Fig 2D) while resting
diameter at 40 mmHg was not changed by the inhibitors (Fig. 2B,
control, 257.5626.16; amiloride, 224.22617.55; 9-phenanthrol,
257.4621.37; SKF96365, 317.00625.51, respectively).
Interactions among ENaC, TRPM4 and TRPC6: Effects of
co-treatment with amiloride, SKF96365, and 9-
phenanthrol on myogenic tone in PCA
To verify the interaction among ENaC, TRPC6, and TRPM4,
we first performed immunofluorescence assay. To determine
whether ENaC and TRPM4 are expressed in the same location,
isolated vessel segments were co-stained with rabbit anti-cENaC
and goat anti-TRPM4 antibodies. As shown in Figure 1B, cENaC
and TRPM4 expression appeared to be clustered in similar
locations within a smooth muscle cell in segmented PCAs. TRPC6
was located near the cell surface but was not co-localized with
ENaC or TRPM4 (Fig. 1A & C). Similar data were obtained using
immunoprecipitation and western blot assays. TRPM4 was
immunoprecipitated from PCA homogenates by anti-ENaC
Figure 3. Effects of co-treatment with amiloride, SKF96365, and 9-phenanthrol on myogenic response. A. Representative recording
showing the effect of co-treatment with 1 mmol/L amiloride and 5 mmol/L 9-phenanthrol. B. Mean data for the effects of amiloride, 9-phenanthrol, or
both inhibitors. Data are shown as means 6 SEM (n=6) *p,0.05 for control vs. treatment with amiloride or 9-phenanthrol or co-treatment with
amiloride and 9-phenanthrol. C. Representative recording showing the effect of SKF96365 on the myogenic response in PCA pretreated with
amiloride and 9-phenanthrol. D. Mean data for the effect of SKF96365 on pressure-induced myogenic tone in PCA pretreated with amiloride and 9-
phenanthrol. Data are shown as means6 SEM (n=6). *p,0.05 for control vs. amiloride and 9-phenanthrol or amiloride, 9-phenanthrol and SKF96365.
{ p,0.05 for amiloride and 9-phenanthrol vs. amiloride, 9-phenanthrol and SKF96365.
doi:10.1371/journal.pone.0084194.g003
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antibody, but TRPC6 was not immunoprecipitated (data not
shown).
The interaction between ENaC and TRPM4 suggested that
ENaC and TRPM4 may have a second role in the regulation of
the myogenic response. To test the biological significance of this
interaction, we tested the effects of amiloride and 9-phenanthol on
pressure-induced myogenic regulation. Inhibitors of ENaC and
TRPM4 attenuated the pressure-induced myogenic response
(Fig. 3A), but co-treatment with amiloride and 9-phenanthrol
did not result in an additional effect on the inhibition of myogenic
tone compared to single treatment with amiloride or 9-phenan-
throl (Fig. 3B). These results suggested cross-talk between the
function of ENaC and TRPM4. Co-treatment with all inhibitors
fully inhibited the myogenic tone (Fig. 3C & D). As shown in
Figure 3B, co-treatment with amiloride and 9-phenanthrol did not
have additional effects on the myogenic tone compared to
individual treatment with each inhibitor. On the other hand, the
pressure-induced myogenic response was entirely inhibited by
SKF96365 treatment in the PCAs co-treated with amiloride and
9-phenanthrol (Fig 3 C & D).
Effects of ENaC, TRPC6, and TRPM4 siRNA on the protein
expression and myogenic constriction in rat PCA
The presence of ENaC, TRPC6, and TRPM4 proteins in PCA
was confirmed by western blot analysis (Fig. 4A) and confocal
microscopy (Fig. 1A, B, C). To obtain direct evidence for the role
of ENaC, TRPC6, and TRPM4 in the development of myogenic
tone, we transfected rat PCA with siRNA, a known post-
transcriptional silencer. Transfection of ENaC siRNA reduced
endogenous ENaC expression up to 80% when compared to non-
targeting (NT) siRNA controls. In addition, TRPC6 and TRPM4
siRNA reduced endogenous expression of the respective proteins
by up to 70% (Fig. 4A). We also investigated the effects of siRNA
of ENaC, TRPC6, and TRPM4 on the pressure-induced
myogenic response in rat PCA. As shown in Figure 4B and C,
treatment with NT siRNA did not affect arterial contractility, but
intraluminal pressure-induced vasoconstriction was inhibited in
the PCAs transfected with targeting siRNAs (Fig. 4B2 & C). In this
study, neither NT siRNA nor targeting siRNAs affected K+-
induced constrictions (data not shown). As a result of these
findings, we concluded that ENaC, TRPC6, and TRPM4 were all
required for the myogenic response induced by an increase of
intraluminal pressure.
Figure 4. Effects of ENaC, TRPC6, and TRPM4 siRNA on the protein expression and myogenic response. A. Western blots showing the
effect of TRPC6, bENaC, or TRPM4 siRNA on the expression of TRPC, bENaC, or TRPM4. Actin was used as a loading control. B. Representative
recording of myogenic response in PCAs transfected with NT siRNA (B1) or TRPC6 siRNA (B2). C. Mean data for the effect of TRPC6-, bENaC-, and
TRPM4-siRNA on pressure-induced myogenic tone. Data are shown as means6 SEM (n= 6). *p,0.05 for control (NT siRNA) vs. transfected with siRNA.
TMP: transmural pressure.
doi:10.1371/journal.pone.0084194.g004
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Interactions among ENaC, TRPM4 and TRPC: Effects of
amiloride, SKF96365, and 9-phenanthrol on myogenic
tone in ENaC, TRPC6, and TRPM4 siRNA transfected PCA
To verify the interaction among ENaC, TRPC6, and TRPM4,
we examined the effects of inhibitors on myogenic responses in
siRNA transfected PCA. In the inhibitor experiments, we detected
co-treatment with amiloride and 9-phenanthrol did not have
additional effects on the myogenic tone compared to individual
treatment with each inhibitor (Fig 3B). Furthermore, we did not
observe additional effects in bENaC siRNA transfected PCA
treated with 9-phenanthrol (Fig. 5A2 & B) and in TRPM4 siRNA
transfected PCA treated with amiloride (Fig. 5B). On the other
hand, the pressure-induced myogenic response was entirely
inhibited by SKF96365 treatment in the PCAs co-treated with
amiloride and 9-phenanthrol (Fig. 3D), and transfected with
bENaC or TRPM4 siRNA (Fig. 6A2 & 6B). Conversely, amiloride
treatment in PCAs transfected with TRPC6 siRNA (Fig. 6B) also
entirely inhibited the pressure-induced myogenic response. These
findings suggested that TRPC6 did not interact with ENaC or
TRPM4 in rat PCA.
Discussion
The myogenic response is characterized by a decrease or
increase of the vessel diameter in response to changes in
transmural pressure, and plays an important role in the
maintenance of ambient vascular tone and the autoregulation of
blood flow of the resistance vasculature. Thus it prevents
transmission of high systemic pressure to the fragile microvascu-
lature [27]. Furthermore, the myogenic response has been
considered as an important factor especially in cerebral circulation
because cerebral arteries are not particularly responded to the
sympathetic nerves surrounding them [28].
It has been also reported that impaired cerebral arterial function
may be responsible for the development of cerebral injury and
edema that can progress to eclampsia, and the myogenic response
is an important auto-regulatory mechanism to control cerebral
arterial function [29,30]. Previous studies in nematodes, flies, and
mammalian hair cells have led to the development of mechano-
sensory models that provide insight into how VSMCs sense and
transduce mechanical signals [31–34]. Although the signal
transduction pathways underlying VSMC contraction have been
investigated, how the increase in pressure triggers vasoconstriction
has remained unclear. Numerous structural elements have been
proposed as participants in the transduction of stretch into cellular
signaling events in VSMCs, including: 1) membrane-bound
enzyme and second messenger systems, 2) activation of ion
transporters and exchangers, and 3) mechanosensitive ion
channels [2,27]. Recently, there have been several reports about
the requirement of ENaC, TRPC6, and TRPM4 proteins for
myogenic constriction [13,14,16,17,35,36]. These reports have
demonstrated the expression of ENaC proteins and the effect of
blocking ENaC protein with amiloride on myogenic constriction
[14,17]. Downregulation of TRPC6 or TRPM4 expression using
antisense oligodeoxynucleotides has been shown to abolish
pressure-induced depolarization and constriction in isolated
cerebral arteries [13,16,35]. Previous studies from our laboratory
also demonstrated that inhibition of ENaC abolishes pressure-
induced vasoconstriction in PCAs [19]. In this study, we
demonstrated for the first time that TRPM4 and TRPC6 as well
as ENaC appeared to be necessary for myogenic constriction in rat
PCAs. We also found that ENaC is functionally linked to TRPM4,
but not to TRPC6. We demonstrated that ENaC, TRPM4, and
Figure 5. Effects of amiloride, and 9-phenanthrol on myogenic tone in ENaC, and TRPM4 siRNA transfected PCA. A1. Representative
recording of myogenic response in PCAs transfected with NT siRNA. A2. Representative recording of the effect of 9-phenanthrol on myogenic tone in
PCA transfected with bENaC-siRNA. B. Mean data for the effect of 9-phenanthrol or amiloride on the pressure-induced myogenic response in PCA
transfected with bENaC or TRPM4 siRNA, respectively. Data are shown as means 6 SEM (n=6). *p,0.05 for control (NT siRNA) vs. transfected with
siRNA, or control vs. transfected with siRNA and amiloride or 9-phenanthrol.
doi:10.1371/journal.pone.0084194.g005
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TRPC6 proteins were expressed in rat PCA using immunostaining
and western blot analysis. Our study revealed that ENaC,
TRPM4, and TRPC6 proteins were expressed and localized near
the membrane of vascular smooth muscle cell (Fig. 1A–C &
Fig. 4A). These results are consistent with previous research
[13,16,35]. The localization pattern is important since the cell
membrane is the site where mechanosensors could be located.
To determine the role of ENaC, TRPM4, and TRPC6 in the
myogenic response, we evaluated the effects of blocking these
channels on the pressure-induced myogenic response in rat PCA.
Two different approaches, inhibitors and siRNA transfection, were
used to investigate whether these channels were required for
myogenic constriction. Similar to the results from previous reports
[14,37], we found that myogenic constriction was inhibited by
amiloride, the ENaC inhibitor (Fig. 2). Pressure-induced vascular
tone was also inhibited by treatment with TRPM4 inhibitor 9-
phenanthrol [38,39], or canonical TRPCs inhibitor SKF96365
[40,41]. The high K+-induced vasoconstriction was not affected by
the inhibitors (data not shown), which means vascular reactivity
was not affected by the inhibitors. The concentrations of inhibitors
applied in our study are half-maximal effective concentrations
(EC50). And these doses are also chosen by several researchers in
the previous studies [42–44]. Although the inhibitors of these
channels attenuated the pressure-induced myogenic response, the
results could not directly prove that ENaC, TRPC6, and TRPM4
proteins function as mechanosensors. In contrast, knock-down
strategies provide strong evidence for the important functional role
of channel subunits in vascular mechanotransduction. Thus, to
strengthen our data, we used a siRNA approach to reduce the
expression of these channels in cerebral arteries. We showed that
bENaC, TRPM4, and TRPC6 siRNA were effective to reduce
protein levels by 70–80% after 3 days of transfection (Fig. 4A).
siRNA transfection did not affect the high K+-induced constriction
(data not shown), but vasoconstriction induced by elevating
intraluminal pressure was inhibited almost 50% in arteries
transfected with siRNAs compared to NT-siRNA-transfected
arteries (Fig. 4C). Our results demonstrated that ENaC, TRPM4,
and TRPC6 proteins play important roles as mechanotransducers
in the myogenic response. Furthermore, we found that myogenic
tone was decreased by ,50% in the presence of amiloride, 9-
phenanthrol and SKF96365 (Fig. 2B).
There has been no evidence that ENaC and TRP channels are
directly or indirectly linked. We therefore performed immunopre-
cipitation and western blot assays to demonstrate binding of TRP
channels to cENaC. We found that TRPM4, but not TRPC6,
coimmunoprecipitated with cENaC from PCA homogenates (data
not shown). Moreover, TRPM4 and cENaC co-localized in the
apical membrane of arterial smooth muscle cells as visualized by
laser-scanning confocal microscopy (Fig. 1B). TRPC6 was also
expressed at the smooth muscle cell membrane, but was not co-
localized with cENaC or TRPM4 (Fig. 1A & 1C). We also found
that actin interacted with cENaC, as previously reported [41]. We
speculated that ENaC interacted with TRPM4 and actin, which is
part of a large, multicomponent protein similar to the established
model of the mechanosensors in VSMCs [27].
Pressure-induced myogenic tone was inhibited by treatment
with amiloride or 9-phenanthrol, but co-treatment with the
inhibitors did not have additional effects on inhibition of the
Figure 6. Effects of amiloride, and SKF96365 on myogenic tone in ENaC, TRPC6, and TRPM4 siRNA transfected PCA. A1.
Representative recording of the myogenic response in PCA transfected with NT siRNA. A2. Representative recording of the effect of SKF96365 on
myogenic tone in PCA transfected with bENaC siRNA. B. Summary of the effects of SKF96365 and amiloride on pressure-induced myogenic tone in
PCA transfected with ENaC, TRPM4, or TRPC6 siRNA. Data are shown as means 6 SEM (n=6). *p,0.05 for control (NT siRNA) vs. transfected with
siRNA or transfected with siRNA and amiloride or SKF96365. #p,0.05 for transfected with siRNA vs. transfected with siRNA and amiloride or
SKF96365.
doi:10.1371/journal.pone.0084194.g006
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myogenic response compared to single inhibitor treatment (Fig. 3A
& 3B). Furthermore, we found that treatment with 9-phenanthrol
or amiloride had similar effects to siRNA transfection of bENaC
or TRPM4 on the myogenic response in PCA (Fig. 5B). These
results suggested that ENaC could be functionally linked with
TRPM4. In addition, these data were in agreement with
immunoprecipitation and confocal microscopy findings.
Our findings, for the first time, suggested a relationship between
ENaC and TRP channels in intact resistance arteries. We
demonstrated that ENaC, TRPM4, and TRPC6 were required
for the development of myogenic response induced by an increase
in intravascular pressure. Co-treatment with amiloride, 9-phenan-
throl and SKF96365 fully inhibited the pressure-induced myo-
genic tone (Fig. 3C & 3D), and SKF96365 had an additional
inhibitory effect on the myogenic response in bENaC or TRPM4
siRNA transfected PCA (Fig. 6B). Moreover, the myogenic
response was fully suppressed by amiloride treatment of
TRPC6-siRNA-transfected PCA (Fig. 6B). These results consis-
tently indicated that TRPC6 did not interact with ENaC or
TRPM4 in rat PCA.
In summary, pressure or stretch induces activation of mechan-
osensitive ion channels and then membrane depolarization and
subsequent Ca2+ influx via voltage dependent Ca2+ channels
(VDCC) largely mediates myogenic contraction (Fig. 7). Further-
more, our findings point to roles of ENaC, TRPM4, and TRPC6
as sensors of mechanotransduction during the myogenic response
induced by an increase in intraluminal pressure. We postulate that
ENaC is functionally linked to TRPM4.
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